EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case–control study of overall survival

✍ Scribed by Faehling, M.; Eckert, R.; Kamp, T.; Kuom, S.; Griese, U.; Sträter, J.; Ott, G.; Spengler, W.

• Book ID: 120362908
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 332 KB
• Volume: 80
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2013.02.010